1
/
of
0
FDA Drug Approval, N012703, ELAVIL
FDA Drug Approval, N012703, ELAVIL
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
NDA: 012703
Company: ASTRAZENECA
Drug Name: ELAVIL
Active Ingredients: AMITRIPTYLINE HYDROCHLORIDE
Strength: 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage Form/Route: TABLET;ORAL
Action Date: 04/07/1961
Marketing Status: Discontinued
Submission Classification: Type 1 - New Molecular Entity
Company: ASTRAZENECA
Drug Name: ELAVIL
Active Ingredients: AMITRIPTYLINE HYDROCHLORIDE
Strength: 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage Form/Route: TABLET;ORAL
Action Date: 04/07/1961
Marketing Status: Discontinued
Submission Classification: Type 1 - New Molecular Entity
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details